ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,469Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 682

$1.65M Total Retail Price of All Prescriptions

Rank: 26 out of 682

815 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 815 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

26% of this provider’s 815 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 22,127 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 919 760 S3 1 1
LEVOTHYROXINE SODIUM 850 747 2 3
LISINOPRIL 693 616 3 2
FUROSEMIDE 591 564 4 7
SIMVASTATIN 568 548 5 4
AMLODIPINE BESYLATE 550 449 6 6
DONEPEZIL HCL 469 446 7 30
WARFARIN SODIUM 430 403 8 13
OMEPRAZOLE 419 331 9 5
DIVALPROEX SODIUM 419 323 9 84
NAMENDA 394 392 11 41
METOPROLOL TARTRATE 382 340 12 10
POTASSIUM CHLORIDE 355 335 13 14
SERTRALINE HCL 348 277 14 24
GABAPENTIN 322 265 15 9
PANTOPRAZOLE SODIUM 316 277 16 29
METFORMIN HCL 311 256 17 8
POLYETHYLENE GLYCOL 3350 288 262 18 44
MIRTAZAPINE 287 276 19 52
ATORVASTATIN CALCIUM 267 233 20 11
CARVEDILOL 266 223 21 23
LOSARTAN POTASSIUM 251 235 22 20
ESCITALOPRAM OXALATE 242 220 23 73
ZOLPIDEM TARTRATE 238 234 24 21
TAMSULOSIN HCL 226 199 25 33
MELOXICAM 219 180 26 27
DIGOXIN 212 211 27 46
CLOPIDOGREL 203 176 28 25
TRAZODONE HCL 199 174 29 38
GLIMEPIRIDE 193 178 30 43
BUSPIRONE HCL 192 177 31 102
HYDROCHLOROTHIAZIDE 184 172 32 12
LEVOFLOXACIN 183 160 33 70
FENTANYL 179 126 S2 34 86
NYSTATIN 168 137 35 95
QUETIAPINE FUMARATE 167 117 36 87
CITALOPRAM HBR 162 146 37 17
ALENDRONATE SODIUM 161 149 38 37
TRAMADOL HCL 154 140 39 26
OXYBUTYNIN CHLORIDE ER 152 127 40 180
DIOVAN 151 141 41 42
PLAVIX 144 137 42 35
IPRATROPIUM-ALBUTEROL 140 133 43 139
LANTUS 137 105 44 55
ATENOLOL 136 129 45 18
EXELON 136 136 45 104
PAROXETINE HCL 131 126 47 53
CRESTOR 125 114 48 22
BISOPROLOL FUMARATE 125 121 48 142
CIPROFLOXACIN HCL 122 111 50 58
RANITIDINE HCL 122 118 50 28
NOVOLOG 121 92 52 129
TRIMETHOPRIM 118 110 53 310
NEXIUM 117 90 54 19
LACTULOSE 115 95 55 100
ALPRAZOLAM 114 92 56 90
SULFAMETHOXAZOLE-TRIMETHOPRIM 111 102 57 103
FENOFIBRATE 110 105 58 76
FLUTICASONE PROPIONATE 110 106 58 36
PRAVASTATIN SODIUM 110 88 58 15
MEGESTROL ACETATE 109 105 R 61 165
CYMBALTA 108 93 62 51
BACLOFEN 106 90 63 130
FLUOXETINE HCL 106 75 63 60
GLIPIZIDE 105 61 65 61
HYDRALAZINE HCL 104 77 66 74
RISPERIDONE 104 102 66 82
AZITHROMYCIN 104 88 66 39
DOXAZOSIN MESYLATE 103 102 69 96
CLONIDINE HCL 102 89 70 48
PATANOL 102 87 70 291
NITROFURANTOIN MONO-MACRO 100 80 72 204
PROMETHAZINE HCL 97 90 R 73 54
ZETIA 97 73 73 69
ISOSORBIDE MONONITRATE ER 95 90 75 31
NOVOLIN R 95 76 75 167
SPIRIVA 95 74 75 49
FINASTERIDE 94 85 78 131
IBUPROFEN 94 69 78 79
SYNTHROID 93 83 80 59
ROPINIROLE HCL 90 57 81 71
BYSTOLIC 90 80 81 118
METOPROLOL SUCCINATE 89 87 83 16
PREDNISONE 89 66 83 40
AMIODARONE HCL 83 81 85 170
ADVAIR DISKUS 82 76 86 47
OXYCODONE-ACETAMINOPHEN 81 76 S2 87 120
TEKTURNA 78 78 88 243
LEXAPRO 78 75 88 222
SPIRONOLACTONE 77 67 90 64
GLYBURIDE 74 66 R 91 72
JANUVIA 73 73 92 62
VESICARE 69 69 93 240
LEVEMIR 69 50 93 185
DILTIAZEM 24HR CD 68 68 95 123
VENLAFAXINE HCL ER 67 55 96 119
PRIMIDONE 67 62 96 228
FAMOTIDINE 66 63 98 99
TRIAMTERENE-HCTZ 64 62 99 57
HALOPERIDOL 64 56 99 238
FLUCONAZOLE 61 53 101 154
CELEBREX 61 59 101 80
GALANTAMINE HBR 60 59 103 288
PROPRANOLOL HCL 60 52 103 141
NYSTOP 59 49 105 282
LANSOPRAZOLE 59 49 105 85
CARBIDOPA-LEVODOPA 58 47 107 121
ALBUTEROL SULFATE 58 51 107 156
IPRATROPIUM BROMIDE 58 57 107 212
CEFTRIAXONE 57 49 110 261
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 47 111 34
ENDOCET 55 23 S2 112 88
EXFORGE 55 55 112 237
LORAZEPAM 54 44 114 158
NITROFURANTOIN 54 43 114 233
LATANOPROST 53 50 116 277
LOPERAMIDE 53 52 116 253
BENAZEPRIL HCL 52 48 118 89
OXYCODONE HCL 52 39 S2 118 93
PRADAXA 52 52 118 231
BUPROPION HCL SR 50 41 121 198
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 26, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.